New program aims to prevent dangerous blood clots in cancer patients
NCT ID NCT07292376
First seen Jan 09, 2026 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tests whether a modified clinical program can improve how doctors prevent blood clots (venous thromboembolism) in cancer patients receiving treatment. About 25 clinicians and their patients will take part. The program includes education for doctors and requires them to assess each patient's risk and discuss prevention. The goal is to see if more patients get the right blood-thinning medication when needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vermont Health
Burlington, Vermont, 05405, United States
Conditions
Explore the condition pages connected to this study.